Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
NLS Pharmaceutics Ltd. See All Filings	D	2025-07-10 16:05:24 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001783036 Filed Document 0001213900-25-062768 Exclusions or Exemptions 506b Accepted Date 2025-07-10 16:05:24 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business SWITZERLAND Revenue or Assets Decline to Disclose Type of Security Equity
NLS Pharmaceutics Ltd. See All Filings	D	2025-04-14 16:01:23 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001783036 Filed Document 0001213900-25-031562 Exclusions or Exemptions 506b Accepted Date 2025-04-14 16:01:23 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business SWITZERLAND Revenue or Assets Decline to Disclose Type of Security Equity
NLS Pharmaceutics Ltd. See All Filings	D	2025-01-22 17:01:31 UTC
Amount To Be Raised $499,999 Associated Brokers / Dealers N/A CIK Number 0001783036 Filed Document 0001213900-25-005558 Exclusions or Exemptions 506b Accepted Date 2025-01-22 17:01:31 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business SWITZERLAND Revenue or Assets Decline to Disclose Type of Security Equity
NLS Pharmaceutics Ltd. See All Filings	D	2024-10-21 17:19:31 UTC
Amount To Be Raised $7,200,000 Associated Brokers / Dealers N/A CIK Number 0001783036 Filed Document 0001213900-24-089358 Exclusions or Exemptions 506b Accepted Date 2024-10-21 17:19:31 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business SWITZERLAND Revenue or Assets Decline to Disclose Type of Security Equity
NLS Pharmaceutics Ltd. See All Filings	D	2024-07-15 09:16:12 UTC
Amount To Be Raised $786,660 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001783036 Filed Document 0001213900-24-061184 Exclusions or Exemptions 506b Accepted Date 2024-07-15 09:16:12 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business SWITZERLAND Revenue or Assets Decline to Disclose Type of Security Equity
NLS Pharmaceutics Ltd. See All Filings	D	2024-04-03 16:01:52 UTC
Amount To Be Raised $1,750,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001783036 Filed Document 0001213900-24-029808 Exclusions or Exemptions 506b Accepted Date 2024-04-03 16:01:52 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business SWITZERLAND Revenue or Assets Decline to Disclose Type of Security Equity
NLS Pharmaceutics Ltd. See All Filings	D	2022-12-21 16:01:29 UTC
Amount To Be Raised $30,000,000 Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. CIK Number 0001783036 Filed Document 0001213900-22-081766 Exclusions or Exemptions 506b Accepted Date 2022-12-21 16:01:29 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business SWITZERLAND Revenue or Assets Decline to Disclose Type of Security Equity
NLS Pharmaceutics Ltd. See All Filings	D	2022-10-14 06:07:51 UTC
Amount To Be Raised $4,000,000 Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. CIK Number 0001783036 Filed Document 0001213900-22-063963 Exclusions or Exemptions 506b Accepted Date 2022-10-14 06:07:51 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business SWITZERLAND Revenue or Assets Decline to Disclose Type of Security Equity